ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ¿µ»ó À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
In-vitro Colorectal Cancer Screening Tests Market Report by Product, Imaging Type, End User, and Region 2025-2033
»óǰÄÚµå : 1722598
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 10¾ï 4,920¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 16¾ï 5,870¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 4.96%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç´Â ´ëÀå¾ÏÀÇ ¼±Á¾, ¿ëÁ¾, ´ëÀå¾ÏÀÇ Áõ»óÀ» ¹ß°ßÇϱâ À§ÇØ ½ÃÇàÇÏ´Â Áø´Ü ÀýÂ÷ÀÔ´Ï´Ù. ´ëÀå¾ÏÀº ´ëÀå, °áÀå, Á÷ÀåÀÇ ¼¼Æ÷°¡ ºñÁ¤»óÀûÀ¸·Î Áõ½ÄÇÏ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â º´À» ¸»ÇÕ´Ï´Ù. ´ëº¯ÀáÇ÷(FOB), Ãø¹æÀ¯µ¿¸é¿ª, Æ®·£½ºÆä¸° ºÐ¼®, ¸Þƿȭ À¯ÀüÀÚ, ¹ÙÀÌ¿À¸¶Ä¿, °úÀÌ¾Ç FOB ´ëº¯°Ë»ç µîÀÌ ÀϹÝÀûÀ¸·Î ½ÃÇàµÇ´Â ¼±º°°Ë»çÀ̸ç, ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç¿¡¼­´Â Ä«¸Þ¶ó¸¦ ÀÌ¿ëÇÏ¿© ¼ÒÈ­°ü ¿µ»óÀ» ÃÔ¿µÇϰí ȯÀÚÀÇ Ç㸮¿¡ ºÎÂøµÈ ·¹ÄÚ´õ·Î Àü¼ÛÇÕ´Ï´Ù. ȯÀÚÀÇ Ç㸮¿¡ ÀåÂøÇÑ ·¹ÄÚ´õ·Î Àü¼ÛÇÕ´Ï´Ù. ÃÖ¼Òħ½ÀÀûÀ̸ç, ¾ÏÀ» Àû½Ã¿¡ ¹ß°ßÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±× °á°ú, ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç´Â Ŭ¸®´Ð, º´¿ø, Áø´Ü ¿¬±¸¼Ò¿¡¼­ ³Î¸® ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù.

ü¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç ½ÃÀå µ¿Çâ:

´ëÁßµé »çÀÌ¿¡¼­ ´ëÀå¾ÏÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ¾ÏÀÇ Á¶±â ¹ß°ß°ú Àû½Ã Ä¡·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¾Ï °ËÁø °Ë»ç¿¡ À¯ÀüÀÚ °Ë»çÀÇ ÅëÇÕ°ú °°Àº ´Ù¾çÇÑ ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â Á¶±â ¹ß°ß, Ä¡·á °èȹ °³¹ß, ¾Ï¼¼Æ÷ È®»ê ¹æÁö, °ü·Ã Áúȯ ¹ßº´ À§Çè ÃÖ¼ÒÈ­¿¡ µµ¿òÀÌ µË´Ï´Ù. ÀÌ¿Í ÇÔ²² ´ëÀå¾ÏÀ» ¹ß°ßÇϱâ À§ÇÑ ÃÖ¼Òħ½À(MI) Áø´Ü¹ý¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Áúº´¿¡ Ãë¾àÇÑ ³ë·É Àα¸ÀÇ Áõ°¡, ÇコÄÉ¾î »ê¾÷ÀÇ È¹±âÀûÀÎ °³¼±, ¾Ï °ËÁøÀ» Àǹ«È­ÇÏ´Â ´Ù¾çÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ½ÃÇà°ú °°Àº ´Ù¸¥ ¿äÀε鵵 ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ Ã¼¿Ü ´ëÀå¾Ï ½ºÅ©¸®´× °Ë»ç ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

Á¦7Àå ½ÃÀå ³»¿ª : ¿µ»ó À¯Çüº°

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global in-vitro colorectal cancer screening tests market size reached USD 1,049.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,658.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.96% during 2025-2033.

In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth of cells in the large intestine, colon and rectum. Fecal occult blood (FOB), lateral flow immuno, transferrin assays, methylated gene, biomarker and guaiac FOB stool test are some of the commonly performed screening tests. In-vitro colorectal cancer screening tests involve the use of cameras that capture images of the digestive tract and transfers them to the recorder tied to the waist of the patient. They are minimally invasive and can aid in timely detection of cancer. As a result, in-vitro colorectal cancer screening tests are widely performed across clinics, hospitals and diagnostics laboratories.

In-Vitro Colorectal Cancer Screening Tests Market Trends:

The increasing prevalence of colorectal cancer among the masses is one of the key factors driving the growth of the market. Moreover, rising awareness regarding the benefits of early detection and timely treatment of cancer is positively impacting the market growth. Various technological advancements, such as the integration of genetic testing in cancer screening tests, are providing a thrust to the market growth. These tests aid in early detection, developing treatment plans, preventing the spread of cancerous cells and minimizing the risks of developing associated disorders. In line with this, the increasing preference for minimally invasive (MI) diagnostic procedures to detect colorectal cancer is favoring the market growth. Other factors, including rising geriatric populations, which is more susceptible to such ailments and significant improvements in the healthcare industry, along with the implementation of various government initiatives mandating cancer screening tests, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

Breakup by Imaging Type:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global In-vitro Colorectal Cancer Screening Tests Market

6 Market Breakup by Product

7 Market Breakup by Imaging Type

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â